Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $3.39 million. The enterprise value is $9.22 million.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, after market close.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 2.09 million shares outstanding. The number of shares has increased by 43.59% in one year.
| Current Share Class | 2.09M |
| Shares Outstanding | 2.09M |
| Shares Change (YoY) | +43.59% |
| Shares Change (QoQ) | +30.94% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 3.66% |
| Float | 2.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.80 |
| Forward PS | 1.21 |
| PB Ratio | 0.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 289.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 3.50.
| Current Ratio | 0.74 |
| Quick Ratio | 0.48 |
| Debt / Equity | 3.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.95 |
Financial Efficiency
Return on equity (ROE) is -388.03% and return on invested capital (ROIC) is -94.73%.
| Return on Equity (ROE) | -388.03% |
| Return on Assets (ROA) | -79.68% |
| Return on Invested Capital (ROIC) | -94.73% |
| Return on Capital Employed (ROCE) | -524.07% |
| Revenue Per Employee | $558 |
| Profits Per Employee | -$663,698 |
| Employee Count | 57 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 3.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.77% in the last 52 weeks. The beta is 1.29, so Eyenovia's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -98.77% |
| 50-Day Moving Average | 3.92 |
| 200-Day Moving Average | 35.85 |
| Relative Strength Index (RSI) | 32.72 |
| Average Volume (20 Days) | 138,871 |
Short Selling Information
The latest short interest is 249,414, so 11.91% of the outstanding shares have been sold short.
| Short Interest | 249,414 |
| Short Previous Month | 4.47M |
| Short % of Shares Out | 11.91% |
| Short % of Float | 11.95% |
| Short Ratio (days to cover) | 0.90 |
Income Statement
In the last 12 months, Eyenovia had revenue of $31,832 and -$37.83 million in losses. Loss per share was -$55.33.
| Revenue | 31,832 |
| Gross Profit | -5.65M |
| Operating Income | -36.75M |
| Pretax Income | -32.44M |
| Net Income | -37.83M |
| EBITDA | -35.65M |
| EBIT | -36.75M |
| Loss Per Share | -$55.33 |
Full Income StatementBalance Sheet
The company has $7.19 million in cash and $13.01 million in debt, giving a net cash position of -$5.82 million or -$2.78 per share.
| Cash & Cash Equivalents | 7.19M |
| Total Debt | 13.01M |
| Net Cash | -5.82M |
| Net Cash Per Share | -$2.78 |
| Equity (Book Value) | 3.72M |
| Book Value Per Share | 3.44 |
| Working Capital | -4.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$30.33 million and capital expenditures -$306,707, giving a free cash flow of -$30.64 million.
| Operating Cash Flow | -30.33M |
| Capital Expenditures | -306,707 |
| Free Cash Flow | -30.64M |
| FCF Per Share | -$14.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -115,461.33% |
| Pretax Margin | -118,845.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.59% |
| Shareholder Yield | -43.59% |
| Earnings Yield | -1,115.34% |
| FCF Yield | -903.31% |
Analyst Forecast
The average price target for Eyenovia is $2.00, which is 23.46% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | 23.46% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 408.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 3, 2025. It was a reverse split with a ratio of 0.0125:1.
| Last Split Date | Feb 3, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0125:1 |
Scores
Eyenovia has an Altman Z-Score of -14.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.49 |
| Piotroski F-Score | 3 |